Cytopoint RSS Authorised This medicine is authorised for use in the European Union lokivetmab Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Cytopoint Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Cytopoint : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 05/05/2017 Last updated: 17/03/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View español (ES) (81.97 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View čeština (CS) (93.99 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View dansk (DA) (83.34 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View français (FR) (82.44 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View íslenska (IS) (83.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View italiano (IT) (82.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View magyar (HU) (94.15 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Malti (MT) (95.95 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View norsk (NO) (82 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View polski (PL) (95.62 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View português (PT) (83.01 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View română (RO) (94.17 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Suomi (FI) (81.54 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View svenska (SV) (82.05 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Product information Cytopoint : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 05/05/2017 Last updated: 17/03/2025 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View español (ES) (81.51 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View čeština (CS) (92.48 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View dansk (DA) (82.05 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Deutsch (DE) (81.72 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View eesti keel (ET) (81.22 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View ελληνικά (EL) (91.79 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View français (FR) (81.63 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View hrvatski (HR) (91.56 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View íslenska (IS) (81.52 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Gaeilge (GA) (81.36 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View italiano (IT) (81.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View latviešu valoda (LV) (92.14 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View magyar (HU) (92.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Malti (MT) (93.86 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Nederlands (NL) (81.15 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View norsk (NO) (81.52 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View polski (PL) (93.22 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View português (PT) (82.53 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View română (RO) (91.73 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenčina (SK) (81.75 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenščina (SL) (81.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Suomi (FI) (81.11 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View svenska (SV) (81.47 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Cytopoint : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 05/05/2017 Last updated: 17/03/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View español (ES) (81.97 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View čeština (CS) (93.99 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View dansk (DA) (83.34 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View français (FR) (82.44 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View íslenska (IS) (83.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View italiano (IT) (82.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View magyar (HU) (94.15 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Malti (MT) (95.95 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View norsk (NO) (82 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View polski (PL) (95.62 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View português (PT) (83.01 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View română (RO) (94.17 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Suomi (FI) (81.54 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View svenska (SV) (82.05 KB - PDF) First published: 05/05/2017 Last updated: 17/03/2025 View Product details Name of medicine Cytopoint Active substance lokivetmab International non-proprietary name (INN) or common name lokivetmab Pharmacotherapeutic groupOther dermatological preparations Authorisation details EMA product number EMEA/V/C/003939 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Cytopoint : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 19/02/2018 Last updated: 17/03/2025 View Cytopoint-V-C-003939-II-0009 : EPAR - Assessment report - VariationAdopted English (EN) (81.49 KB - PDF)First published: 15/09/2021 Last updated: 17/03/2025 View CVMP post-authorisation summary of positive opinion for Cytopoint (II-0009)Adopted Reference Number: EMA/CVMP/446877/2020 English (EN) (139.68 KB - PDF)First published: 11/09/2020 View Initial marketing authorisation documents Cytopoint : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 05/05/2017 Last updated: 17/03/2025 View CVMP summary of positive opinion for CytopointAdopted Reference Number: EMA/CVMP/44548/2017 English (EN) (68.41 KB - PDF)First published: 17/02/2017 Last updated: 17/02/2017 View News on Cytopoint Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 202316/06/2023 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 202110/12/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 10-12 May 202117/05/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 19-20 January 202122/01/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 202011/09/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-18 March 202020/03/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 201913/09/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-22 May 201924/05/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 15-16 April 201923/04/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19-21 March 201922/03/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 201814/09/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 March 201816/03/2018 First monoclonal antibody in veterinary medicine recommended for a marketing authorisation17/02/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 14-16 February 201717/02/2017 Topics Medicines This page was last updated on 17/03/2025 Share this page